BAXTER 0.18% SODIUM CHLORIDE and 4% GLUCOSE 1000mL injection AHB1254 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 0.18% sodium chloride and 4% glucose 1000ml injection ahb1254

baxter healthcare pty ltd - glucose, quantity: 40 g/l; sodium chloride, quantity: 1.8 g/l - injection, solution - excipient ingredients: water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.18% SODIUM CHLORIDE and 4% GLUCOSE 500mL injection AHB1253 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 0.18% sodium chloride and 4% glucose 500ml injection ahb1253

baxter healthcare pty ltd - glucose, quantity: 40 g/l; sodium chloride, quantity: 1.8 g/l - injection, solution - excipient ingredients: water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.244% POTASSIUM CHLORIDE and 0.18% SODIUM CHLORIDE and 4% GLUCOSE 1000mL injection AHB1224 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 0.244% potassium chloride and 0.18% sodium chloride and 4% glucose 1000ml injection ahb1224

baxter healthcare pty ltd - glucose, quantity: 40 g/l; potassium chloride, quantity: 2.24 g/l; sodium chloride, quantity: 1.8 g/l - injection, solution - excipient ingredients: water for injections - the potassium chloride (0.224%), sodium chloride (0.18%), and glucose (4%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.15% Potassium Chloride and 0.18% SODIUM CHLORIDE and 4% GLUCOSE 1000mL injection BPAHB1704 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 0.15% potassium chloride and 0.18% sodium chloride and 4% glucose 1000ml injection bpahb1704

baxter healthcare pty ltd - potassium chloride, quantity: 1.5 g/l; sodium chloride, quantity: 1.8 g/l; glucose, quantity: 40 g/l - injection, solution - excipient ingredients: water for injections - the potassium chloride ( 0.15%) and sodium chloride (0.18 %) and glucose (4 %) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

Sodium Chloride 0.18% w/v Glucose 4%w/v Solution for infusion Irland - engelsk - HPRA (Health Products Regulatory Authority)

sodium chloride 0.18% w/v glucose 4%w/v solution for infusion

maco pharma - sodium chloride; glucose monohydrate - solution for infusion - 0.18/4 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates

Sodium Chloride 0.18% w/v Glucose 4%w/v Solution for infusion Irland - engelsk - HPRA (Health Products Regulatory Authority)

sodium chloride 0.18% w/v glucose 4%w/v solution for infusion

carelide - sodium chloride; glucose monohydrate - solution for infusion - 0.18/4 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates

MACO PHARMA SODIUM CHLORIDE Irland - engelsk - HPRA (Health Products Regulatory Authority)

maco pharma sodium chloride

maco pharma (uk) ltd - sodium chloride ; glucose monohydrate - solution for infusion - %w/v - electrolytes with carbohydrates

GLUCOSE 5 % INTRAVENOUS INFUSION BP Israel - engelsk - Ministry of Health

glucose 5 % intravenous infusion bp

teva medical marketing ltd. - glucose monohydrate - solution for infusion - glucose monohydrate 5.5 %w/v - glucose - glucose - glucose 5 % intravenous infusion is indicated for the treatment of carbohydrate and fluid depletion. glucose 5 % is also used as a vehicle and diluent for compatible medicinal products for parenteral administration.

GLUCOSE 5 % INTRAVENOUS INFUSION BP Israel - engelsk - Ministry of Health

glucose 5 % intravenous infusion bp

teva medical marketing ltd. - glucose monohydrate - solution for infusion - glucose monohydrate 5.5 %w/v - glucose - glucose - glucose 5 % intravenous infusion is indicated for the treatment of carbohydrate and fluid depletion. glucose 5 % is also used as a vehicle and diluent for compatible medicinal products for parenteral administration.

GLUCOSE 5 % INTRAVENOUS INFUSION BP Israel - engelsk - Ministry of Health

glucose 5 % intravenous infusion bp

teva medical marketing ltd. - glucose monohydrate - solution for infusion - glucose monohydrate 5.5 %w/v - glucose - glucose - for the treatment of carbohydrate and fluid depletion. glucose 5 % is also used as a vehicle and diluent for compatible medicinal products for parenteral administration.